|
ACH |
Air change per hour |
|
AFB |
Acid-fast bacilli |
|
AIDS |
Acquired immunodeficiency syndrome |
|
Amk |
Amikacin |
|
Amx/Clv |
Amoxicillin/clavulanic acid |
|
ARI |
Annual risk of infection |
|
ART |
Antiretroviral therapy |
|
ARV |
Antiretroviral |
|
BCG |
Bacillus Calmette-Guérin |
|
Bdq |
Bedaquiline |
|
CDC |
United States Centers for Disease Control and Prevention |
|
Cfz |
Clofazimine |
|
Cm |
Capreomycin |
|
CMX |
Cotrimoxazole |
|
CPC |
Cetylpyridinum chloride |
|
CPT |
Cotrimoxazole preventive therapy |
|
Cs |
Cycloserine |
|
CXR |
Chest X-ray |
|
DOT |
Directly observed therapy |
|
DR |
Drug resistance |
|
DR-TB |
Drug-resistant tuberculosis |
|
DST |
Drug susceptibility test(ing) |
|
E |
Ethambutol |
|
ECG |
Electrocardiogram |
|
EPTB |
Extrapulmonary tuberculosis |
|
Eto |
Ethionamide |
|
FDC |
Fixed-dose combination |
|
FNAC |
Fine needle aspiration cytology |
|
FQ |
Fluoroquinolone |
|
GFR |
Glomerular filtration rate |
|
H |
Isoniazid |
|
HCW |
Health care worker |
|
HIV |
Human immunodeficiency virus |
|
HPF |
High-power field |
|
IC |
Infection control |
|
IM |
Intramuscular |
|
Imp/Cln |
Imipenem/cilastatin |
|
IPT |
Isoniazid preventive therapy |
|
IRIS |
Immune reconstitution inflammatory syndrome |
|
IUATLD |
International Union against Tuberculosis and Lung Disease |
|
Km |
Kanamycin |
|
LFT |
Liver function test |
|
Lfx |
Levofloxacin |
|
LPA |
Line probe assay |
|
Lzd |
Linezolid |
|
MDR |
Multidrug resistance |
|
MDR-TB |
Multidrug-resistant tuberculosis |
|
Mfx |
Moxifloxacin |
|
MGIT |
Mycobacteria growth indicator tube |
|
MODS |
Microscopic observation of drug susceptibility |
|
Mpm |
Meropenem |
|
NNRTI |
Non-nucleoside reverse transcriptase inhibitor |
|
NRTI |
Nucleoside reverse transcriptase inhibitor |
|
NTM |
Non tuberculous mycobacteria |
|
Ofx |
Ofloxacin |
|
PAS |
Para-aminosalicylic acid |
|
PCP |
Pneumocystosis |
|
PCR |
Polymerase chain reaction |
|
PI |
Protease inhibitor |
|
PO |
Orally (per os) |
|
Pto |
Prothionamide |
|
R |
Rifampicin |
|
Rfb |
Rifabutin |
|
RR |
Rifampicin resistance |
|
S |
Streptomycin |
|
TAT |
Turn around time |
|
TB |
Tuberculosis |
|
Thz |
Thioacetazone |
|
TLA |
Thin-layer agar |
|
TSH |
Thyroid-stimulating hormone |
|
TST |
Tuberculin skin test |
|
UVGI |
Ultraviolet germicidal irradiation |
|
WHO |
World Health Organization |
|
XDR |
Extensive drug resistance |
|
XDR-TB |
Extensively drug-resistant tuberculosis |
|
Z |
Pyrazinamide |